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ABSTRACT
The Role of Chitinase A in Mastitis-Associated
Escherichia coli Pathogenesis
Weston D. Hutchison
Department of Microbiology and Molecular Biology, BYU
Master of Science
Bovine mastitis is a common disease among dairy cattle characterized by the
inflammation of the udders and loss of milk production. Mastitis-associated Escherichia
coli (MAEC) are frequent causes of the disease, but the features that distinguish them
from other E. coli strains remain enigmatic. MAEC infections can range from subclinical to severe, acute cases that can be fatal. Historically, the severity of mastitis has
been attributed to host factors but more recently, a few bacterial genes have been shown
to contribute to virulence in mastitis infections. In a large-scale genomic analysis of
>100 MAEC isolates the gene for Chitinase A (ChiA) was positively associated with
robust growth in the mammary glands during a mouse model of mastitis. This
correlation suggests the hypothesis that ChiA contributes directly to MAEC fitness.
The regulation of chiA has not been documented in contexts relevant to bovine
mastitis. In the lab strain K-12, chiA is not expressed during aerobic growth in rich
media. However, previous work with enterotoxigenic E. coli strain H10407 indicated
that expression may be induced by hypoxic environments and the presence of bile salts.
To measure expression of chiA, I created a chiA-GFP reporter plasmid and measured
changes in fluorescence using flow cytometry. My results indicate promoter activity of
chiA in MAEC is significantly increased in hypoxic conditions and the presence of bile
salts, but not both. Adhesion to host tissues is an important characteristic of successful
pathogens. Since ChiA facilitates adhesion between adherent-invasive E. coli and
intestinal epithelial cells, I investigated its role in adhesion to bovine mammary
epithelial cells in four MAEC strain backgrounds. Isogenic mutants lacking chiA were
made in 2 mild (M45 and M93) and 2 severe (M111 and G1) clinical isolates. Loss of chiA
resulted in significant reduction of adherence of M45, M93, and G1 to epithelial cells,
but not M111. Wild type levels of adhesion were restored upon reintroduction of chiA
into mutants through a plasmid vector. Additionally, the genomes of each MAEC isolate
were analyzed for the presence of genes that could possibly influence the adhesion and
virulence. Strain M111 contained genes for 2 distinct fimbriae that were not present in
the other MAEC strains, possibly reducing its reliance on ChiA.
The interaction of ChiA with mammary epithelial cells in MAEC could possibly
offer an advantage for certain strains to be better suited to colonize and persist in
mammary glands. Increased understanding of the regulation of chiA and its role in
adherence can lead to novel targets for more effective treatment and prevention of
bovine mastitis.
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SECTION 1: INTRODUCTION
1.1 Bovine Mastitis
Mastitis is a common condition in dairy cattle, defined as an inflammatory
response in the mammary gland, usually as a result of a bacterial infection. It is
characterized by swelling and redness of the udders, milk that is watery or contains pus,
as well as an increased somatic cell count (SCC) of leukocytes, neutrophils, and
macrophages in milk [1]. Bovine mastitis can be characterized in 3 classes: clinical, subclinical, and chronic. These classes are based on the symptoms and level of
inflammation in the cow [2]. Mastitis is commonly diagnosed by a SCC in milk above
200,000 cells/mL with the level of inflammation being proportional to the SCC [3].
Clinical mastitis is characterized by a sudden onset of pain and inflammation in
the cow’s udder. Their milk may also present with clots, flakes, or a watery consistency.
Clinical mastitis can be further subdivided into per-acute, acute, and sub-acute,
dependent on the level of inflammation and severity [4]. Sub-clinical mastitis is
characterized by the lack of visible symptoms in the milk or udder but decreased milk
production and an increased SCC. This is often unnoticed or misdiagnosed making it a
higher risk condition for older cows [4]. Sub-clinical mastitis is estimated be 15 to 40
times more prevalent than clinical mastitis [5] and therefore cause a more significant
economic impact. One study found a prevalence of sub-clinical mastitis to be up to
42.5% in cows on medium sized farms [6].
Chronic mastitis involves recurrent symptomatic episodes, often as a result of
incomplete clearing of a previous case of mastitis. Biofilms make the bacteria more
recalcitrant to the host immune response and antimicrobial treatment, which likely
1
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contributes to the development of chronic mastitis [2, 3, 7]. Incomplete clearing of a
mastitis infection or over use of antibiotics can lead to the emergence of antibiotic
resistance in these pathogens [8], an issue recognized as a significant risk to global
health.
Any type of mastitis infection puts a cow at risk for damage to their mammary
gland which can lead to decreased milk production and further health complications [9].
This can lead to a persistent decrease in milk production for the cow and even lead to an
earlier culling of cows that produce less milk or have chronic mastitis [4].
1.1.1 The Impacts of Bovine Mastitis Worldwide
Bovine mastitis is mostly caused by bacterial infections which can be classified
based on their epidemiological origin: contagious and environmental. The former is
mainly caused by bacteria like Staphylococcus aureus, Streptococcus spp., and
Mycoplasma spp. These often spread from an infected cow to an uninfected one
through worker’s hands, towels, or equipment from milking [10]. S. aureus is the
predominant causative agent of contagious mastitis. Not only has S. aureus been wellstudied in general, but it is also arguably one of the most well characterized mastitis
pathogens [11]. The incidence of bovine mastitis caused by S. aureus can reach 100% in
dairy herds whose regular prevalence ranges from 30-50% [12]. In a wide range of
countries worldwide, S. aureus is the most common bovine mastitis isolate [11, 13-18].
This high incidence has led to concern of zoonotic spillover of methicillin-resistant S.
aureus (MRSA) strains into human populations with some studies showing that bovine
isolates of MRSA are genetically similar to human isolates [12, 14], indicating this
spillover is already occurring.
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Environmental infections are mostly caused by Escherichia coli, Enterobacter
aerogenes, and Klebsiella spp. commonly originating in the environment around the
cow such as their bedding material, soil, manure, feces, and stagnant water [10]. E. coli
is the most frequently isolated environmental pathogen. While mastitis-associated E.
coli (MAEC) does not have many well-understood virulence factors like other extraintestinal pathogenic E. coli, MAEC is the most common cause of recurrent mastitis, or
mastitis caused by the same bacterial strain in multiple instances. Döpfer et al sampled
dairy cows from 300 herds and found that 11% of all mastitis cases caused by E. coli
were considered recurrent [3]. In a separate study of over 20,000 cows in the
Netherlands, 30% of diagnosed cases were caused by E. coli [19], making it one of the
most common and costly pathogens in bovine mastitis.
The cost of mastitis can range from USD$200-450 per case [20, 21] when
product loss, treatment, diagnosis, and other costs are considered. This results in almost
$2 billion just in product loss every year in the United States [21, 22]. The largest
contributor to these losses is sub-clinical mastitis cases, which can be caused by both
environmental and contagious pathogens. In a recent study done in Ecuador, the
estimated economic impact of sub-clinical mastitis in over 12,000 cows across 55 farms
was USD$800,000 per year in the region with this impact being most noticeable in
small to medium sized farms [6]. A separate study in Bangladesh estimated the regional
impact of sub-clinical mastitis to be USD$2.1 million per year [23].
It is estimated that worldwide consumption of dairy products will increase by 1%
each year between 2019-2028 [24], meaning dairy production will need to increase to
meet the coming demand. The European Union (EU) has projected that dairy
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production will increase by 0.2% per year in New Zealand, 1% per year in the United
States, and <3% per year in developing countries [25], making mastitis a significant
concern when it comes to the current and future health of dairy animals as well as a
worldwide economic concern. This highlights the need for better understanding of
mastitis pathogens and more effective diagnostic and treatment methods.
1.1.2 Diagnosis of Bovine Mastitis
The diagnosis of bovine mastitis is a critical step in prevention, treatment, and
control [26-28]. Early diagnosis reduces the risk of permanent damage to the mammary
gland, recurring infections, chronic mastitis, and loss of milk production. Unfortunately,
due to the variety of presentations of bovine mastitis, it can be very difficult to diagnose
in a timely manner.
Diagnosis can be made through multiple different methods, each with their own
advantages and drawbacks. Most commonly, the SCC is used as the primary indicator,
absent any obvious physical or behavioral symptoms exhibited by the cow. SCCs are
determined by the number of white blood cells in milk which are primarily,
lymphocytes, polymorphonuclear neutrophils, and macrophages [29]. An SCC of
200,000 cells/mL is considered to signal a case of mastitis [30], though this number
varies depending on the normal SCC of the cow, the pathogen, and the measurement
method. Measurement of certain biomarkers such as N-acetyl-β-D-glucosaminidase and
lactate dehydrogenase can also be used for a diagnosis. Finally, culturing and/or
identifying the causative organism is another common method of diagnosis.
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1.1.3.1 Diagnosis Through Somatic Cell Count and Biomarkers
The California Mastitis Test, developed by Schlam and company in 1957, is one of
the most used methods for diagnosing bovine mastitis through SCC [31]. This test works
by lysing somatic cells in the milk. The resulting cell lysate reacts with reagents in the kit
to create two indicators of SCC: the formation of a gel and the appearance of a purple
color. Sodium alkyl aryl sulfonate is used to lyse cells and facilitate the formation of a gel
[32]. As a result of the sudden lysis, the pH of the solution can change, making it more
alkaline; this is indicated by the presence of bromocresol purple. In addition, released
proteins and DNA will react with the sodium alkyl aryl sulfonate, increasing the
viscosity of the solution. The level of viscosity and varying shades of purple in the
sample can be used to estimate the SCC, though it is not nearly exact.
This test can be used at the side of the cow and is relatively affordable, with 350
tests being available for ~USD$12 [33]. However, despite its relative ease of use and low
price, it is not widely available or accessible in relatively low-income areas and countries
[34]. It can also lead to false positive results if a cow naturally has a higher SCC than the
kit determines as negative as well as due to low sensitivity and difficult or variable
interpretation of results [33].
Other methods are useful to determine SCC such as direct microscopic counting,
Coulter counting, fluoro-optic electronic cell counts, or flow cytometry. Directly
counting cells with stains such as methylene blue provides a more accurate SCC and can
be done relatively quickly. Directly counting somatic cells can be challenging though,
since it can be difficult to differentiate between cytoplasmic particles and cells [35].
Coulter counting is done by fixing somatic cells with formaldehyde, adding a lysis buffer
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to remove fat cells, and counting them using a machine that detects the changes in an
electrical current as the cells pass through. Alternatively, flow cytometry is a reliable
method that provides very accurate and precise counts. It works well on fresh and
preserved samples of milk, requiring little to no treatment beforehand. When combined
with fluorescent markers, flow cytometry provides a high-throughput, relatively
affordable method for determining SCC [36]. However, all of these methods require
skilled labor and specialized equipment, making them inaccessible to many farms
around the world.
An alternative method of diagnosing bovine mastitis is by quantifying biological
markers that are present in milk during clinical cases. Comparative proteomics between
healthy and diseased cows provides a highly specific (~100%) and sensitive (~75%)
diagnostic method [37, 38]. Recently, milk amyloid A was found to be strongly
correlated to SCCs in both clinical and sub-clinical mastitis cases [39]. Other enzymes
such as alkaline phosphatase and milk arginase have also been identified as potential
diagnostic markers [40-42]. The levels of these enzymes and markers are most
affordably and accurately measured with immunological assays such as enzyme-linked
immunosorbent assays (ELISA) [43].
1.1.3.2 Diagnosis by the Identification of Causative Organisms
Isolating the causative organism in a mastitis infection is one of the most
accurate methods of diagnosis and leads to more targeted treatments for the cow. This
can be done through traditional methods such as growing and isolating colonies of the
bacteria or through genetic testing such as polymerase-chain reaction (PCR) and
sequencing.
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Differential and selective media such as mannitol salt agar for Staphylococcus
spp., eosin-methylene blue agar for E. coli, or pleuropneumonia-like organism (PPLO)
medium for Mycoplasma spp. are used for more accurate identification with growth.
The sensitivity of selective media is comparable to PCR in the identifying pathogens that
are often difficult to culture like Mycoplasma spp [44]. In conjunction with isolation
and growth of the organism, PCR can be used to further characterize the causative
organism.
PCR testing is a very quick, sensitive, and specific method to diagnose mastitis
and can be combined with sequencing for genes such as 16s rRNA [44]. Results can be
available within 1-2 days, reducing time to treatment. The sensitivity and specificity can
range from 76.9%-100% and 63.3%-98.7%, respectively [44-46], depending on the
targets of the PCR. Multiplex PCR tests have been developed that offer advantages over
traditional 16s rRNA PCR and sequencing, such as ease of use, sensitivity, and
specificity [47]. In addition to accurate identification of bacterial species in mastitis,
PCR has also been used to great effect to identify antibiotic resistance genes in these
pathogens allowing for more targeted treatments [45].
Determining microbial etiology for mastitis, especially sub-clinical mastitis, can
increase positive outcomes for treatment and the health of the animal [48]. However,
10-40% of milk samples of clinical and sub-clinical mastitis cases show no growth with
bacteriological examination [49]. A multitude of explanations could be given as to why
this is: Mycoplasma spp. require special culturing methods and media [50], growth of
the pathogen may take too long, or one bacteria may suppress the growth of a competing
bacteria in culture. While culturing of causative microorganisms is considered the gold
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standard for diagnosing bovine mastitis, false negative rates between 27%-50% have
been reported[13, 51-53].
1.1.4 Antimicrobial Treatments of Bovine Mastitis
The proper treatment of mastitis is a vital part of controlling the condition and
preventing future health issues for the animals. Historically, antimicrobial therapy has
been the most common method of treatment for mastitis, dating back to soon after the
discovery of antimicrobials [54-57]. However, its effectiveness today can be extremely
limited, due to the overuse of antibiotics in agriculture and livestock [58-61]. The
success of treatment may also be reduced by the administration route (intramammary
infusion vs systemic), the type of antibiotics used, and the causative agent [26].
Antimicrobials such as macrolides (e.g., erythromycin), tetracyclines, and
trimethoprim-sulfonamides exhibit reduced activity in milk, making them less effective
when administered via intramammary infusion [54, 62, 63]. Systemic administration of
antimicrobials is thought to be more effective, theoretically being able to more broadly
penetrate mammary tissue [64]. However, systemic administration can inadvertently
lead to an increase in antimicrobial resistance of bacteria in the gastrointestinal tract, an
issue that is of growing concern in public and global health [8, 12, 57, 61, 65, 66].
Antimicrobial resistance reduces the effectiveness of current treatments. Rasheed
et al. showed that over 14% of E. coli isolated from food sources such as milk, beef, and
poultry, were resistant to one or more commonly used antibiotic [67]. Similarly, MRSA
was found on 29.6% of sampled cows in China [15]. Issues like these can also lead to
increased prevalence of chronic and sub-clinical mastitis. Antimicrobial residues can
also persist in milk following treatment [68], highlighting the need for a better
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understanding of the pathogenesis of mastitis-associated bacteria as well as
investigation into more effective treatments.
1.2 Extraintestinal Pathogenic and Mastitis-Associated E. coli
E. coli is one of the most ubiquitous gram-negative organisms in the world. It is a
member of the family Enterobacteriaceae and can be found in the intestinal tract of
most mammalian species and birds. E. coli bacteria mostly behave as a commensal
organism though many strains are considered pathogenic. Most pathogenic E. coli
strains cause intestinal illness, but many other strains are especially suited for causing
infection outside of the intestines. These are called extraintestinal pathogenic E. coli
(ExPEC).
ExPEC can cause a wide variety of illnesses. They are the leading cause of urinary
tract infections [69, 70], second most common cause of neonatal meningitis [71, 72],
and the most prevalent cause of sepsis from gram-negative bacteria [73]. These ExPEC
infections lead to increased healthcare costs, morbidity, and lost productivity [74].
Despite a large impact on global health, ExPEC has not reached the public eye as much
as intestinal pathogens, likely due to a relatively constant endemicity in most areas [75].
This has led to a lack of awareness and less research on ExPEC strains than other areas
of E. coli pathogenesis.
E. coli strains can be placed into phylogroups according to the presence or
absence of four specific genes (Groups A, B1, B2, C, D, E, F, Clade I). Phylogroup
analysis is of limited value in predicting the pathogenic potential of E. coli strains
including those that cause mastitis. However, ExPEC tend to be from different
phylogenetic groups than their intestinal pathogenic relatives. Intestinal pathogens are
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predominantly from phylogroup A, B1, or D [76] while ExPEC isolates are mostly
grouped into phylogroup B2 and followed by group D [77-84]. This is in contrast to
commensal strains of E. coli, which are predominantly in phylogroup A and B1 [82, 85].
Most isolates of MAEC are also part of phylogroup A and B1 [86-92] with phylogroup A
being heavily associated with pathogenic strains in animals [88].
E. coli is the most frequently isolated Gram-negative organism in bovine mastitis
[2-4, 20, 22]. For a long time, the severity of mastitis was thought to be mainly
dependent on host factors such as immune response, lactation stage, and anatomy [93].
Colonization of the udder by E. coli most commonly occurs in early stages of lactation
and during calving [94] and during the dry period, a time when the cow is most at risk
for coliform mastitis [60]. Doses as small as 50 colony-forming units (CFUs) can induce
an immune response [95].
Following infection, milk can begin to appear clotted and thick [96], the animal
can start to feel pain at the site of infection and develop an acute fever [97]. Typically,
after 48 hours from the initial onset, symptoms can disappear or reduce to unnoticeable
levels if the inflammation was mild. However, some severe inflammatory responses can
cause endotoxic shock resulting in permanent health issues or even death of the cow
[93]. Even following successful treatment, the udder may sustain permanent damage
from an acute MAEC infection.
1.2.1 Putative Virulence Factors Found in MAEC are Poorly Understood
E. coli has a wide variety of virulence factors that allow it to cause a broad range
of infections among many different hosts (Table 1-1). Some MAEC also carry these genes
including those that code for biofilms [98], capsule synthesis [99], and serum resistance

11
[100, 101]. Unfortunately, very few studies have tested their contribution to virulence in
mastitis models of infection [102]. Lehtolainen et al. analyzed the genomes of over 150
MAEC strains isolated from clinical mastitis cases in Finland and compared the
prevalence of each putative virulence factor found with the clinical presentation of each
strain. They showed that some virulence factors (P and S fimbriae, CNF1 and CNF2)
were strongly correlated with the phenotype of persistent cases of clinical mastitis, while
none were correlated with the severity of the infection [102]. Capsule production, zinc
uptake, and iron scavenging through the ferric dicitrate receptor all directly influence
the ability of MAEC to grow in mouse mammary glands [99]. However, very few
putative virulence factors have been tested for their role in experimental mammary
gland infections, leaving their impact in MAEC virulence largely enigmatic.
Table 1-1: Virulence Factors Found in MAEC
Virulence Factor

Role

Reference

Fimbriae/Afimbriae (AfaE-8†, P and S

Adhesion

[101, 103-108]

Intimin† (eae)

Adhesion

[103, 105, 109]

Aerotaxis Receptors†

Detection of O2

[110]

fimbriae**, LPF1†, LPF2†, Type 1
fimbriae)

niches
Biofilm associated genes† (fliC, fimA,

Protection against

csgA, luxS)

host defenses and

[111, 112]

antimicrobials
Polysaccharide Capsule (Group III)*

Protection from
phagocytosis and
destruction by
macrophages

[99]
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Iron Transport systems (yersiniabactin†,

Iron acquisition

enterobactin†, sitABCD†, fecABCDE*)

and transport to

[101, 113, 114]

E. coli
Zinc Uptake (znuABC*)

Zinc acquisition

[99, 115]

and protein
function
Shiga toxins† (Stx1, Stx2)

Induction of

[116-118]

apoptosis of
mammary cells
A review by Nawel Zaatout, 2022 contains more information about these virulence factors [119].
*These genes have been experimentally shown to contribute to colonization of mammary glands
†These genes have been verified as important for the virulence of other pathogenic E. coli but
have not been experimentally shown to contribute to colonization of mammary glands

1.2.1.1 Biofilms are Thought to Contribute to MAEC Persistence
Biofilms are a community of bacteria that produce a polymeric extracellular
matrix consisting of saccharides, DNA, or proteins [98, 120-123]. The process of
forming a biofilm can be divided into 4 steps: reversible adhesion, irreversible adhesion,
biofilm maturation, and dispersion [124]. Once the biofilm is formed, it can act as a
protective barrier against many different environmental pressures such as
antimicrobials [125], phagocytic host immune cells [126, 127], and oxidative stress
[128].
The initial adhesion of E. coli to a biotic or abiotic surface can be facilitated by
many different factors. Hydrodynamic and electrostatic forces of the environment and
surface are overcome using flagellar propulsion allowing the bacterium to loosely or
reversibly bind to the target surface [129, 130]. This reversible binding is usually caused
by forces like van der Waals interactions, temperature, steric hindrance, or hydrophobic
forces [130, 131]. The magnitude of these forces and ability of the bacterium to overcome
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them largely depends on the surface. If the surface exhibits more repulsive forces
towards the bacterium, it will not be able to attach effectively.
Following the reversible adhesion to the surface, E. coli can irreversibly bind to
the surface using pili, fimbriae, or surface proteins [129]. Soon after, the bacterium can
begin to produce components of the extracellular matrix such as autotransporters [132]
and extracellular polymeric substances [133]. Other molecules such as quorum sensing
autoinducers like N-acyl-homoserine lactones will also be produced and exported into
the surrounding environment to modify gene expression of the bacterial community at
large [134]. This can lead to increased expression of motility and virulence factors such
as fimbriae and heat-labile toxins [135], which have been described in many MAEC
strains (Table 1-1).
In an in vitro model of bovine mammary epithelial cells, non-adherent S. aureus
was markedly more sensitive to antimicrobial treatment than adherent staphylococci
[136], suggesting that biofilm formation is beneficial to the survival of bacteria during
treatment. Biofilm formation occurs in MAEC strain P4 during both mouse and bovine
models of infection, however, its role in pathogenesis and virulence is not yet
understood but likely contributes to persistence in the mammary gland [137].
1.2.1.2 Polysaccharide Capsules Contribute to MAEC Virulence
Capsules are produced by a wide variety of both non-pathogenic and pathogenic
bacteria [138-141]. In E. coli, capsules typically consist of polysaccharides that are
produced by the cell and exported to the space around the cell. The primary components
of the extracellular polysaccharides (LPS, O antigens, and capsular or K antigens) are
serotype specific. The serotype of these antigens can be used to predict virulence of the
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bacterium [142]. There are over 150 serogroups of O antigens and more than 80
serotypes of K antigens (see the Complex Carbohydrate Structure Database,
https://ccrc.uga.edu/) [143].
Some MAEC strains make capsules that are vital to their success as a pathogen.
M12 is a strain of MAEC that was found to make a Group III capsule. Olson et al. found
that when they disrupted capsule synthesis by deleting kpsC and kpsS the virulence of
M12 was completely eliminated in Galleria mellonella and slightly reduced in mouse
mammary gland model of infection [99]. In subsequent work, this capsule was found to
be indispensable in causing sepsis and colonization of kidneys in a urinary tract model
of infection [138].
1.2.1.3 Adhesion is Important for Persistent MAEC Infection
Adhesion and invasion of epithelial cells has long been described as an important
factor for the success of many pathogenic E. coli strains [144]. The ability to adhere to
host cells allows the bacterium to not only colonize host tissues but persist in areas that
it may not otherwise be able to. Pili and fimbriae are the most well-understood adhesins.
Fimbriae are rod-like structures 5-10 nanometers in diameter and can reach lengths of
greater than 10 micrometers [145]. In MAEC, genes encoding P and S fimbriae have
been significantly correlated with strains that cause chronic mastitis [102], suggesting
that adhesion mammary epithelial cells is important for continuous infection of a
mammary gland.
Proteins other than fimbriae also contribute to bacterial adhesion and invasion of
host cells. NlpI is an outer membrane lipoprotein found in all E. coli that is important in
meningitis and intestinal infections caused by pathogenic E. coli [146, 147]. Intimin is
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another adhesion factor that has been found in several different strains of MAEC [103,
105, 109] (See Table 1). It is expressed in both enteropathogenic E. coli (EPEC) and
enterohemorrhagic E. coli (EHEC) [148]. Intimin binds an epithelial cell surface
protein, Hp90, and the translocated intimin receptor and allows the bacterium to
strongly adhere to the cell surface [149]. Genes encoding for both intimin and
translocated intimin receptor have been found in MAEC but any possible contribution to
virulence has yet to be investigated [150].
Persistent bacterial infections frequently involve adhesion, invasion, and
intracellular replication of the pathogen in host cells [151]. Döpfer et al demonstrated
that some MAEC possesses the ability to invade and persist in mammary epithelial cells
[152]. MAEC strains isolated from persistent mastitis infections display much higher
rates of invasion of bovine mammary epithelial cells than their transient counterparts
(10.6-fold difference) and similar rates of adhesion [153], suggesting that these initial
steps of colonization are important in the progression of the disease.
Olson et al. analyzed the genomes of >100 MAEC isolates after identifying which
isolates were more successful in both mouse and bovine models of infection [115].
Isolates that were more prevalent in later stages of infection were significantly more
likely to possess a gene called chiA, a putative periplasmic chitinase, adjacent to a type 2
secretion system (T2SS) [99]. A separate analysis of over 800 publicly available
genomes was performed on commensal and pathogenic E. coli strains. Commensal
strains were isolated from the intestines of healthy avian (chicken or turkey) or bovine
hosts while pathogenic strains were isolated from lesions of disease such as bovine
mastitis or avian colibacillosis. Pathogenic isolates were much more likely to have chiA
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(formerly yheB), a putative bifunctional lysozyme/chitinase, and its T2SS in their
accessory genome than the commensal strains (79.9% vs 47.0%, respectively) [Olson et
al., Unpublished data]. These findings indicated chiA might play a role in MAEC
pathogenesis.
1.3 Chitinase A and its Possible Role in MAEC Adherence to Host Cells
Chitin is a biopolymer consisting of a repetitive chain of β-(1,4)-N-acetyl-Dglucosamine units. It is found in arthropods [154], fungi [155], and cephalopods [156]
and is the second most abundant biological molecule after cellulose [157, 158]. While
mammals do not synthesize chitin, they possess a family of proteins called number-18
glycoside hydrolases. This protein family consists of 2 subfamilies: chitinase proteins
and chitinase-like proteins [159, 160]. The former can both bind and digest chitin
molecules via hydrolysis while the latter binds chitin molecules but lacks the ability to
digest them. Many bacteria also possess genes for chitinase proteins. The soil-dwelling
gram-negative bacterium, Serratia marcescens, effectively degrades chitin and using
three unique number-18 chitinases, ChiA, ChiB, and ChiC [161, 162]. In some species,
chitinases can degrade other N-acetyl glucosamine containing polysaccharides like
peptidoglycan [163], suggesting these proteins may serve multiple purposes.
E. coli cannot fully digest and metabolize long chains of chitin. However, it can
grow on the disaccharide, N,N’-diacetlychitobiose (GlcNAc2) [164]. ChiA degrades
GlcNAc2 and N, N’,N”-triacetylchitotriose into singular GlcNAc units [165]. In the lab
strain K-12, ChiA is negatively regulated by the nucleoid-structuring protein, H-NS [165,
166]. While ChiA is regularly found in the periplasm, it is exported outside of the cell, a
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characteristic common among bacterial chitinases [167], via the T2SS that is frequently
encoded adjacent to it [165].
Chitinases are increasingly being recognized as important virulence factors in
both enteric pathogens [168-170] and non-enteric pathogens [171-173]. In Salmonella
enterica serovar Typhimurium, chitinases promote adhesion and invasion of intestinal
epithelial cells through modification of the host glycoproteins [174]. Specifically,
Salmonella chitinase cleaves the terminal sialic acid and Gal-β-1,4 acetyl glucosamines
to make the mannose residues more accessible to the bacteria, which are targets of type
I pili. These chitinases also increase immune evasion by up-regulating production of
reactive nitrogen and oxygen species in intracellular bacteria to reduce the host immune
response in phagocytes by causing down regulation of MHC-II, preventing the antigen
presentation by both activated macrophages and dendritic cells [175].
Legionella pneumophila chitinases are required for colonization of the lungs due
to their ability to degrade mucin [173, 176]. L. pneumophila secretes its chitinase protein
(LP-ChiA) through a T2SS in a similar manner as E. coli. Following secretion, LP-ChiA
associates with the outer leaflet of the outer membrane [176]. ChiA from MAEC shares a
high level of homology with both L. pneumophila and Salmonella chitinases (see
Supplementary Figure 12). This homology is mainly concentrated in the regions of
MAEC ChiA that have been previously described as chitin-binding domains (residues
25-567) [177].
MUC1 is a glycoprotein found on the surface of mammary epithelial cells in cows
[178]. MUC1 is highly polymorphic and extensively glycosylated [179]. It also binds to E.
coli strain K-12, preventing adhesion to mammary epithelial cells. MUC1 transcription is
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upregulated in response to the presence of LPS, indicating that it is part of the innate
immune response in coliform mastitis [179]. It is possible that ChiA binds to or digests
portions of MUC1 preventing it from inhibiting adherence to mammary epithelial cells,
similar to how other species of pathogenic bacteria use chitinase to degrade mucin or
glycoproteins to promote colonization [174-176] though this has not been investigated.
Adherent-invasive E. coli (AIEC) strain LF82 was isolated from the chronic ileal
lesion of a Crohn’s patient [180]. Low et al. showed that in the absence of ChiA, LF82
does not adhere well to human intestinal epithelial cells. In addition, N-glycosylation
was critical for the adhesion of LF82 to epithelial cells [177]. They showed this
interaction was due to binding to the host protein, Chitinase 3-like-1 (CHI3L1). In
addition to its function in intestinal cells, CHI3L1 is also expressed on the surface of
mammary and in milk as a consequence of inflammation from coliform mastitis [159].
CHI3L1 is found in a wide range of mammalian species [181], suggesting an important
role in defense of mucosal epithelial cells. Whether ChiA acts as an adhesive factor
during MAEC infection has not been investigated.
1.4 Summary
The wide range of severity and clinical presentation of mastitis infections by
MAEC is impressive. Recently, work has begun to characterize the putative virulence
factors of MAEC and find correlations or relationships with severity or presentations of
mastitis. However, these studies are in their infancy, with few directly testing the role of
these factors in the pathogenesis of this disease.
The role of ChiA in MAEC has not yet been investigated. The chiA gene is present
at significantly higher rates in MAEC strains that are more competitive during
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experimental infection [115] as well as in pathogenic strains of both avian pathogenic
and mastitis-associated E. coli. suggesting it plays an important role in the ability of
MAEC to colonize and persist in mammary glands. Further characterizing the
expression of ChiA and identifying its role in adhesion to mammary epithelial cells is the
focus of this thesis. Understanding the role ChiA plays in the pathogenesis and
progression of mastitis would lead to a better understanding of this disease, potentially
identifying a novel target for antimicrobial therapies, treatments, and vaccines.
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SECTION 2: MATERIALS AND METHODS
2.1 Bacterial strains and media
All bacterial strains were routinely grown in Luria-Bertani (LB) (Tryptone 10 g/L,
NaCl 10 g/L, Yeast Extract 5 g/L, if applicable agar 15 g/L) media at 37°C unless
otherwise stated. Liquid cultures were grown shaking at 22o rpm unless specified
otherwise. Antibiotics were added to media as required for growth of mutants and
maintenance of plasmids (chloramphenicol 10 μg/mL, ampicillin 100 μg/mL,
gentamicin 10 μg/mL). The donor E. coli strain MFDpir was grown in LB plus diaminopimelic acid (DAP) (Sigma, #D1337) at 330 μM concentration. Super-Optimal
Broth (SOB) (tryptone 20 g/L, yeast extract 5 g/L, 10 mM NaCl, 2.5 mM KCl, 10 mM
MgSO4, 10 mM MgCl2) [182] was used for growth of strains prior to transformation.
Transformations were recovered in SOB with catabolite repression (SOC) (SOB with 20
mM glucose).
Each strain used in this thesis, their clinical presentation, location each MAEC
strain was isolated, Clermont Type, and multilocus sequencing type (MLST) is listed in
Table 2-1.
Table 2-1: List of Strains used in this Study

Name
M45

Genotype or Main
Characteristic
Mild, clinical MAEC

Clermont MLST
Type
C
ST23

M93

Mild, clinical MAEC

A

ND*

M111

Severe, clinical MAEC

A

ST10

G1

Severe, per-acute clinical
MAEC

B2

ST95

Location
Isolated/Source
Ontario, Canada
[99]
Ontario, Canada
[99]
Alberta, Canada
[99]
Idaho, USA
This Study
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MFDpir

MG1655 RP4-2Tc::(ΔMu1::aac(3)IVΔaphA-Δnic35-ΔMu2::zeo)
ΔdapA::(erm-pir) ΔrecA

[183]

*ND=Not determined

2.2 Generation of Knock-out Mutants in MAEC Strains
2.2.1 Creation of pAX1 Allelic Exchange Plasmid
Primers to make the construct to knock-out chiA were designed as described by
Wiles et al. [184]. First, a region of ~500 bp upstream and a region of ~500 bp
downstream of chiA was amplified using PCR. Protocols for these PCR reactions for
these regions are described in Table 2-2 as PCR1. The forward upstream primer (primer
003) contained a SalI recognition site (SalI: GTCGAC) on the 5’ end and the reverse
downstream primer (primer 006) contained an AvrII recognition site (AvrII: CCTAGG)
on its 5’ end for future insertion into the pAX1 plasmid. The reverse upstream (primer
004) and forward downstream primers (primer 005) each contained tails of the reverse
complement of the other primer. This provides an area of overlap to allow the upstream
and downstream sequences to be “stitched” together. All primers used for this are listed
in Table 2-4.
After both the upstream and downstream sequences were amplified, these two
products were “stitched” together using the PCR2 protocol laid out in Table 2-2. The
resulting PCRs were separated on a 0.8% agarose gel. Bands at the correct size (~1,000
bp) were excised and DNA was isolated using Zymoclean™ Gel DNA recovery kit (Zymo
Research, #D4001) according to the manufacturer’s instructions.
Next, the isolated stitch PCR product was digested using SalI-HF (New England
Biolabs, #R3138) and AvrII (New England Biolabs, #R0174) according to the
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manufacturer’s recommendations. The pAX1 plasmid was digested using the same
restriction enzymes and protocol. The digested stitch PCR product was isolated using
Monarch© PCR & DNA Cleanup Kit (New England Biolabs, #T1030). The digested pAX1
plasmid was separated on a 0.8% agarose gel, then the band was excised and isolated
using Zymoclean™ Gel DNA recovery kit (Zymo Research, #D4001).

Figure 2-1: Creation of pWH02 from pAX1

Finally, the digested stitch PCR product and digested pAX1 were ligated together
using T4 DNA Ligase (New England Biolabs, #M0202) according to the manufacturer’s
suggested protocol in a 20 μL reaction carried out at room temperature for 60 minutes.
This resulted in pWH02. Then 2 μL of the reaction was transformed via electroporation
into the donor E. coli strain MFDpir. Transformants were selected for by plating on
LB+Amp+DAP. This resulted in strain MFDpir1.
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Table 2-2: Upstream and Downstream Region Amplification for pAX1 Plasmid
25 μL PCR1 Reaction:
12.5 μL Q5 Master Mix
1 μL genomic E. coli DNA
1.25 μL Primer 003/oo5
1.25 μL Primer 004/006
9 μL mgH2O*
25 μL PCR2 Reaction:
12.5 μL Q5 Master Mix
1.25 μL Primer 003†
1.25 μL Primer 006†
1 μL Upstream PCR1 product**
1 μL Downstream PCR1 product**
8 μL mgH2O*

PCR1 Protocol:
1) 98°C for 30 sec
2) 98°C for 10 sec
3) 60°C for 15 sec
4) 72°C for 15 sec
5) Go to Step 2—30X
6) 72°C for 5:00
7) Hold at 4°C
PCR2 Protocol:
1) 98°C for 30 sec
2) 98°C for 10 sec
3) 55°C for 30 sec
4) 72°C for 30 sec
5) Go to Step 2 – 10X
6) Add primers to 500 nM
7) 98°C for 10 sec
8) 60°C for 15 sec
9) 72°C for 30 sec
10) Go to Step 7 – 20X
11) 72°C for 5:00
12) Hold at 4°C

*mgH2O=molecular grade H2O
† primers should not be added to the reaction until Step 6. This allows for the two PCR products to stitch
together and amplify as a single amplicon
** both upstream and downstream products should be added to the reaction in equimolar amounts.
Adjust mgH2O as needed.

2.2.2 pAX1 Mating Reactions and Mutant Screening
Overnight cultures of both the target strain and donor strain MFDpir containing
pWH02 were sub-cultured into fresh media at a 1:1,000 dilution and incubated at 37°C
and 30°C, respectively, until an OD600 of 0.4-0.5. After this, 750 μL of the target strain
and donor with were each combined in a 1.5 mL microcentrifuge tube and cells were
pelleted by centrifugation at 10,000xG for 1 min. Supernatant was discarded and cells
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Figure 2-2: Mating Reactions with MFDPIR+pWH02 to Create Merodiploids

were resuspended in 50 μL of LB+DAP, then placed on a 25 mm filter disk with 0.45 μm
pores. This was incubated at 30°C for 4-6 hours.
Following the co-incubation, the bacteria were dislodged from the filter disk by
vortexing in 500 μL sterile PBS. 100 μL of this mixture and 100 μL of a 1:10 dilution was
plated on LB agar with ampicillin and gentamicin and incubated overnight at 37°C to
select for insertion of the plasmid into the chromosome. Colonies that exhibited mild
fluorescence were considered potential merodiploids. Merodiploid colonies were grown
in LB broth for 6 hours at 37°C, serially diluted, and plated on LB agar. Single colonies
that had lost any noticeable fluorescence were chosen and analyzed with PCR to verify
deletion of chiA using primers 001 and 002 (internal) or primers 003 and 006
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(external). Gels of each wild type and ΔchiA mutant with these primers are shown in
Figures 2-3 and 2-4.

Figure 2-3: Gel of Wild Type and ΔchiA Mutants Tested with External Primers.
ΔchiA mutants were screened for using primers 003 and 006. The wild type strains gave
bands ~3.7 kb while ΔchiA mutants gave bands ~800-900 bp.
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Figure 2-4: Gel of Wild Type and ΔchiA Mutants Tested with Internal Primers.
ΔchiA mutants and wild type MAEC strains were screened using internal chiA primers 001
and 002. Wild type strains showed a band ~450 bp while no band was present for ΔchiA
mutants.

2.3 Transformation of Plasmids
Plasmids were transformed into bacteria using either heat-shock or
electroporation. Heat-shock was used to propagate cloning plasmids before being reisolated and electroporated into target strains. For heat-shock, NEB© 5-alpha
Competent E. coli (New England Biolabs, #C2987H) was thawed on ice for 5 minutes.
Then, 1-5 μL containing 1-100 ng of plasmid was added to cells and mixed by flicking.
This mixture was placed on ice for 45 minutes before heat-shocking in a 42°C heating
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block for 30 seconds. The mixture was then placed back on ice for 5 minutes before
adding 950 μL of SOC. The culture was then incubated shaking (220 rpm) at 37°C for 1
hour before plating on LB with the appropriate antibiotic for selection of transformants.
For electroporation, an overnight culture of cells was diluted 1:1,000 in fresh SOB
and grown at 37°C to an OD600 of 0.4-0.5 (2-3 hours). 1 mL of culture was pelleted by
centrifuging at ≥16,000 rcf for 1 minute at 4°C. The supernatant was discarded, cells
were washed in 1 mL of ice-cold 10% glycerol, and pelleted again. This was repeated for
a total of 3 washes. Following the final wash, cells were resuspended in 75 μL of ice-cold
10% glycerol. Then, 10-500 ng of plasmid was added to the cells and they were
electroporated using a MicroPulser Electroporator (Bio-Rad, #1652100) on the Ec1
setting (1 pulse at 1.8 kV, time constant 2.5s) in an ice-cold 1mm cuvette (Genessee,
#40-103). Cells were recovered with 900 μL of fresh SOC and incubated at 37°C for 1
hour with shaking (220 rpm) and 100 μL was plated on LB with the appropriate
antibiotic to select for transformants and incubated at 37°C overnight.
2.4 Complementation of Knockout Mutants
The chiA gene was reintroduced into each knockout mutant by cloning the gene
into pJET1.2 (ThermoFisher, #K1231) This was done by amplifying chiA including 300
bp upstream to include the putative promoter using primers 007 and 008 (Table 2-4)
and ligating the resulting product into pJET1.2 according to the manufacturer’s
instructions. This created plasmid pWH01. This was then transformed by heat-shock
into NEB© 5-alpha Competent E. coli (New England Biolabs, #C2987H) and plated on
LB with ampicillin overnight. Successful transformants were screened for using colony
PCR with primers pJET1.2 forward and pJET1.2 reverse. Colonies containing the
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plasmid with the correct insertion were grown overnight in Terrific Broth (Tryptone 12
g/L, yeast extract 24 g/L, 0.4% glycerol (v/v), potassium phosphate monobasic 2.3 g/L,
potassium phosphate dibasic 16.4 g/L) with ampicillin overnight. pWH01 was then
isolated using ZR Plasmid Miniprep kit (Zymo Research, #D4016) and transformed via
electroporation (see section 2.3).
2.5 MAC-T Cell Culture and Media
Bovine mammary alveolar epithelial cells (MAC-T cells) were generously sent to
our lab by Dr. Janos Zempleni (University of Nebraska-Lincoln). They were grown in T75 flasks with 40% (v/v) Dulbecco’s Modified Eagle Medium (DMEM), 40% (v/v) Ham’s
F12 Medium (Corning, #10-092-CM), and 10% (v/v) FetalPURE™ bovine serum (FBS)
(Genessee, #25-525). FBS was heat-inactivated prior to use in media by incubating in a
56°C water bath for 30 minutes with periodical mixing. This was supplemented with
bovine insulin, 5 μg/mL (Millipore-Sigma, #I0516), hydrocortisone, 1 μg/mL (Sigma,
#H0888), HEPES buffer, 23 mM (Sigma, #H3375), sodium bicarbonate, 2.2 g/L (Fisher
Scientific, #S233-500), and L-glutamine, 40 mM (Sigma,#G6392). Penicillin,
Streptomycin (100 U/mL and 100 μg/mL, respectively) (ThermoFisher, #15140122) and
Amphotericin B (2.5 μg/mL) (Sigma, #A2942) were added into the media for routine
growth. MAC-T cells were grown at 37°C and 5% CO2 (v/v).
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pACYC184::yadE::gfp
ΔtetR

pWH03

Figure 2-5: Creation of pWH03 Using PCR

2.6 Flow Cytometry and GFP Expression Reporter
pWH03 is a GFP reporter plasmid that was created by amplifying a previous
plasmid made in lab (pACYC184::yadE::GFPΔtet) [185] using primers 012 and 013
(Table 2-5) and inserting the sequence for the chiA promoter region in front of the GFP.
This PCR reaction is detailed in Table 2-3 under “Plasmid linearization PCR”. The PCR
reaction was treated with DpnI to remove residual plasmid by adding 20 U of DpnI
(New England Biolabs, # R0176) directly to the PCR reaction and incubating at 37°C for
1 hour. This reaction was inactivated by incubating at 80°C for 10 minutes. The
promoter sequence for chiA was amplified with primers 010 and 011 which both
contained overlap with the reporter plasmid. This PCR reaction is detailed in Table 2-4
under “Promoter PCR”. Both reactions had their respective products cleaned and
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isolated using Monarch© PCR & DNA Cleanup Kit (New England Biolabs, #T1030).
These two PCR products were then ligated together using overlap-extension PCR. The
protocol for this PCR reaction is detailed in Table 2-3 under the “Overlap-PCR”
protocol. This was then transformed via heat-shock into NEB© 5-alpha Competent E.
coli (New England Biolabs, #C2987H) as outlined in section 2.3. G1 was transformed
with pWH03 using electroporation to create G1/PWH03.
For hypoxic conditions, a 5.0 L anaerobic jar (BD Biosciences, #260672) with 1,
2.5 L anaerobic generation sachet (ThermoFisher, #68061-10SATCHETS-F) was used.
Samples were also grown in the presence of bile salts at 1.5% (w/v) in LB broth. Aerobic
conditions were created by shaking samples at 220 rpms. All samples were incubated at
37°C overnight (16-18 hrs) before being analyzed. 50 μL of the cultures were suspended
in 950 μL of sterile PBS.
The suspension of bacteria was then measured through the FL-1 channel on a BD
Accuri™ C6 Flow Cytometer (BD Biosciences). 10,000 events were measured and
backgated gated to only include singlets with a fluorescence measurement greater than
1. The observed fluorescence was normalized to the fluorescence G1/pWH04 which
contained a plasmid with no promoter sequence in front of the gfp. This was done 2
times with each sample being measured in triplicate.
pWH04 was created according to the “Plasmid Linearization PCR” protocol listed
in Table 2-3. The resulting linear construct was then digested using SalI (New England
Biolabs, #R3138L) and DpnI. The resulting digested product was then cleaned and
reisolated. This was ligated together without an insert using T4 Ligase and the reaction
was transformed into G1 measured via electroporation to create G1/pWH03.
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Table 2-3: PCR Reactions to create pWH03 and pWH04
Plasmid Linearization PCR

Plasmid Linearization PCR Protocol

25 μL reaction

1) 98°C for 30 sec

12.5 μL Q5 Master Mix

2) 98°C for 10 sec

1 μL pACYC::yadE::GFP::Δtet

3) 58°C for 15 sec

1.25 μL primer 011‡

4) 72°C for 1:00

1.25 μL primer 012‡

5) Go to Step 2—30X

9 μL mgH2O*

6) 72°C for 5:00

Promoter PCR

Promoter PCR Protocol

25 μL reaction

1) 98°C for 30 sec

12.5 μL Q5 Master Mix

2) 98°C for 10 sec

1 μL genomic E. coli DNA

3) 58°C for 15 sec

1.25 μL primer 009

4) 72°C for 10 sec

1.25 μL primer 010

5) Go to Step 2—30X

9 μL mgH2O*

6) 72°C for 5:00

Overlap PCR

Overlap PCR Protocol

25 μL reaction

1) 98°C for 30 sec

12.5 μL Q5 Master Mix

2) 98°C for 10 sec

2 μL Promoter PCR product†

3) 72°C for 2:00

1 μL Plasmid Linearization PCR product†

4) Go to Step 2—20X

9.5 μL mgH2O*

5) 72°C for 5:00

*mgH2O=molecular grade H2O
†The promoter PCR product should be present at 2x the molar amount than the plasmid linearization
PCR product. Adjust MgH2O as needed.
‡Primers are replaced with 013 and 014 when creating pWH04

2.7 Adhesion assays
MAC-T cells were seeded into a 12-welled plate and grown to ≥95% confluency.
The density of epithelial cells was determined by trypan blue exclusion and counting
using Cell Counter model R1 automated cell counter (Olympus). Approximately 6x105
MAC-T cells were present in each well. The number of cells and viability did not vary
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throughout the assays as determined by trypan blue exclusion. On the day of each assay,
spent media was removed from each well and MAC-T cells were washed 3x with 1 mL of
sterile PBS to remove residual antibiotics from media and unhealthy cells. 1 mL of
media without antibiotics was added into each well and MAC-T cells were allowed to
incubate for ≥2 hours prior to inoculation with bacteria.
Overnight cultures of bacteria were diluted in sterile PBS to an OD600 of 0.5.
Bacteria was added to a multiplicity of infection (MOI) of 10 bacterial cells to 1 MAC-T

Figure 2-6: Workflow of Adhesion Assays.
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cell (approx. 6x106 bacteria, MOI=10:1). The 12-well plates were then centrifuged at
300xG for 5 min at room temperature in order to synchronize contact of bacteria with
MAC-T cells. Plates were then incubated at 37°C and 5% CO2 (v/v) for 1 hour. Following
incubation, media was aspirated out of the wells and washed 3 times with 1 mL of sterile
PBS to dislodge weakly adhered bacteria. 500 μL of 0.1% Triton X-100 (Sigma, #X100)
in PBS was then added into each well and incubated at room temperature for 5 minutes
to lyse MAC-T cells. The resulting suspension of bacteria was then serially diluted and
plated on LB overnight and CFUs were counted. This was repeated two times and
measured in triplicate.
2.8 Primers and Plasmids
All primers and plasmids used are listed in Tables 2-4 and 2-5, respectively.
Table 2-4: Primers used in this Study
Primer
001

Sequence
GGTTGCGGATCAGGCATCTA

002

GCGTCAATTTCTGCATCGCT

003

gcaggtcgacTAATGCCGGGCGACAACAT

004

gcggcgatactggaaggtattCCCTTGTGACGTAAAAACTGC

005

gcagtttttacgtcacaagggAATACCTTCCAGTATCGCCGC

006

cagtcctaggTTGAGACGTTTGAGACCCCAG

Function
Forward internal
primer for chiA
Reverse internal
primer for chiA
Upstream forward
of chiA with SalI
site for
construction of
pWH02
Upstream reverse
of chiA for
construction of
pWH02
Downstream
forward of chiA for
construction of
pWH02
Downstream
reverse of chiA with
AvrII site for
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007

CGTTTCGCAATCCGTGAAGG

008

GCGGCGATACTGGAAGGTAT

009

tatctcttcaaatgtagcacTGCATTTGTTGGCTGTATATC

010

agttcttctcctttacgcattATAATCCCTTGTGACGTAA

011

ttacgtgcacaagggattatAATGCGTAAAGGAGAAGAACT

012

gatatacagccaacaaatgcaGTGCTAACATTTGAAGAGATA

013

gcaggtcgacAATGCGTAAAGGAGAAGAACT

014

gcaggtcgacGTGCTAACATTTGAAGAGATA

pJET1.2
Forward

CGACTCACTATAGGGAGAGCGGC

pJET 1.2
Reverse

AAGAACATCGATTTTCCATGGCAG

construction of
pWH02
Forward primer to
amplify chiA
Reverse primer to
amplify chiA
Forward primer for
chiA promoter to
create pWH03
Reverse primer for
chiA promoter to
create pWH03
Forward primer to
linearize
pACYC184::yadE::
GFPΔtet to create
pWH03
Reverse primer to
linearize
pACYC184::yadE::
GFPΔtet to create
pWH03
Forward primer for
null reporter
plasmid pWH04
Reverse primer for
null reporter
plasmid pWH04
Forward primer for
verification of
insertions into
pJET1.2
Reverse primer for
verification of
insertions into
pJET1.2

Table 2-5: Plasmids used in this Study
Plasmid

Description

Source

pJET1.2/blunt

pBM1, AmpR, eco47IR, T7 promoter

ThermoFisher
(Cat# K1231)

35
pWH01

pJET1.2/blunt with chiA cloned into position

This Study

369
pAX1

pSC101, Rep101(Ts), GmR, AmpR, TetR, GFP

[184]

pWH02

pAX1, ΔchiA

This Study

pACYC184::yadE::GFPΔtet pACYC, CmR, GFP, yadE promoter

[185]

pWH03

pACYC, CmR, GFP, chiA promoter

This Study

pWH04

pACYC, CmR, GFP, no promoter

This Study

pKD46

repA101, AmpR, araBAD, λgam/bet/exo,

[186]

2.9 Identification of Virulence Factors
Virulence factors were identified by using Virulence Factor Database 2.0
(Institute of Pathogen Biology, Beijing, http://www.mgc.ac.cn/VFs/) [187]. The
assembled draft genomes were submitted to the database in Genbank format.
2.10 Multisequence Alignment of Glycosyl Hydrolase Family 18 Proteins
Genes encoding glycosyl hydrolase family 18 (GH18) proteins from Salmonella
enterica serovar Typhimurium strain 14028S, S. enterica serovar Typhi strain CT18,
and Legionella pneumophila strains C9_S and 130b were aligned to the protein
sequence for ChiA from MAEC strain G1 using constraint based multiple alignment tool
(COBALT) on the NCBI website. The alignment was viewed and edited using Jalview
[188].
2.11 Statistical analysis
All statistical analysis was done using Prism9 (GraphPad). Differences in
adhesion assays were analyzed using a one-way analysis of variance (ANOVA) with
Tukey’s correction for multiple comparisons. Differences in chiA expression from flow
cytometery and plate reader values from pWHo6 were determined using a Mann-
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Whitney U test. A p-value less than or equal to 0.05 was considered statistically
significant.
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SECTION 3: RESULTS AND DISCUSSION
Based on previous work demonstrating the role of ChiA in adhesion to intestinal
epithelial cells, I hypothesized that ChiA would play a similar role in adhesion to bovine
mammary epithelial cells. I also hypothesized that expression of chiA would be
increased in hypoxic environments, such as the milk of a cow with mastitis. Oxygen
levels in milk have been found to be up to 90% lower in cows with mastitis and high
somatic cell counts [189, 190]. Milk from mastitis cases also contains bile salts, which
increase over the course of the infection [191], possibly as a result from increased serum
uptake in the mammary gland [192]. MAEC also originates from fecal matter of cows,
where bile salt concentrations can reach 1.1% [193]. As such, I predicted that expression
of chiA would increase in the presence of bile salts. To determine the effect of
environmental conditions on expression of ChiA, fluorescence of strain G1 containing
pWH03, a GFP reporter plasmid with the chiA promoter, was measured in hypoxic
conditions and in the presence of bile salts.
The role of ChiA in adhesion to mammary epithelial cells was investigated by
creation of isogenic mutants and then measuring levels of adhesion observed in an in
vitro environment. Four strains were investigated: M45, M93, M111, and G1. M45 and
M111 were both successful in bovine mammary glands in a competitive experimental
model of infection (John Lippolis and Michael Olson, unpublished data). M45 and M93
were isolated from mild cases of clinical mastitis. M111 was isolated from a severe case
of clinical mastitis. G1 was isolated from a case of severe, gangrenous mastitis and
caused significant clinical symptoms in the affected cow.
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3.1 Expression of chiA is Increased in Hypoxic Environments and in the Presence of
Bile Salts, but not both
To explore environments that could lead to changes in expression of chiA, I used
a reporter plasmid that contained a GFP marker with the putative chiA promoter
sequence directly upstream (pWH03). The putative promoter was amplified based on
previous primer extension analysis that defined the transcriptional start site as
approximately 35 base pairs upstream of chiA to be the promoter, with the -35 and -10
boxes being discernable as well [166]. As such, I amplified an area of 241 bp
immediately upstream of chiA using primers 013 and 014 (see Table 2-4) for creation of
pWH03. This plasmid was transformed into strain G1 via electroporation. A control
plasmid lacking a promoter sequence upstream of gfp (pWH04) was also created and
transformed into G1.
G1 containing either pWH03 or pWH04 were incubated in LB broth in aerobic
and hypoxic conditions as well as in the presence of varying concentrations (0.5%, 1.0%,
and 1.5% w/v) of bile salts. These environments were chosen due to recent data that
indicated chiA transcription increased in LB with 0.5% (w/v) bile salts or with low
oxygen in enterotoxigenic E. coli (ETEC) [194]. Cultures were grown overnight (16-18
hrs) and diluted 20-fold in sterile PBS for measurement by flow cytometry. The median
fluorescence of G1 containing pWH04 was subtracted from the values of pWH03.
Results are presented in Figure 3-1. Histograms showing representative samples from 2
different measurements are shown in Figure 3-2.
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Figure 3-1: Adjusted Median Fluorescence of G1 with pWH03 in Hypoxia and/or Bile Salts.
MAEC strain G1 was incubated conditions with hypoxia, 1.5% (w/v) bile salts, and a
combination of both. The average adjusted median fluorescence is shown with error bars
indicating a 95% confidence interval. Significance was determined by a Mann-Whitney U-Test.
Each sample was compared to standard aerobic conditions (black). **p<0.05. BS=Bile Salts

When grown in the presence of 1.5% bile salts, G1 showed increased promoter
activity. Standard aerobic conditions had an average adjusted median fluorescence of 5.18 while 1.5% bile salts were 18.92. This was considered significantly different than
under (p=0.022). In addition, when G1 was cultured in hypoxic conditions, promoter
activity was further increased. Hypoxic conditions had an average adjusted median
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Experiment 1

Experiment 2

A

B

C

D

Figure 3-2: Histograms of Fluorescence Values of G1 with pWH03 or pWH04.

Histograms with representative samples from 2 separate experiments
showing the fluorescence values of G1 with pWH03 (blue) or pWH04 (red) in
aerobic conditions (A), 1.5% (w/v) bile salts (B), hypoxic conditions (C), and
hypoxic conditions with 1.5% bile salts (D). The number of events is shown on
the y-axis and the fluorescence value is shown on the x-axis.
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fluorescence of 52.77. This was also significantly different than aerobic conditions
(p=0.022).
Surprisingly, the combination of hypoxia and 1.5% bile salts did not change promoter
activity of chiA. These conditions had an average adjusted median fluorescence of
approximately -8.22. There was no statistical difference between aerobic conditions and
hypoxia with 1.5% bile salts (p=0.776).
While I showed that promoter activity of chiA is increased in both hypoxic
conditions and in the presence of 1.5% bile salts, this assay does have limitations. Bile
salts are made of up multiple different types of molecules which are present in different
concentrations depending on the location in the intestinal tract. In Vibrio
parahaemolyticus, a two-component signaling system is able to bind bile salts that pass
through the outer membrane, altering gene expression and inducing expression of
certain virulence factors such as a type III secretion system [165, 177]. This also only
occurs when certain bile salts are bound [195]. It is possible this may be true for MAEC
since E. coli contains similar systems [196]. This assay used a premade mixture of bile
salts which may not be representative of the bile salt components present in the
mammary gland during mastitis.
This assay is also limited in the fact that it does not provide a direct measurement
of chiA transcript or ChiA protein levels, so any post-transcriptional or posttranslational regulation that may occur is not apparent. Other approaches such as qPCR
and Western blotting would help confirm the results presented here. It may also be
beneficial to establish whether the H-NS protein represses chiA in multiple MAEC
strains as previously described in lab strain K-12 [165, 177]. If so, I would predict
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conditions leading to repression of H-NS such as over expression of Lon protease or
PhoP mediated-displacement would lead to increased expression of chiA [197].
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3.2 ChiA plays a Significant Role in Adhesion to MAC-T cells in Certain MAEC Strains
To test the role of ChiA in adhesion to epithelial cells, I created markerless
deletion mutants using the pAX1 plasmid (See Section 2.2) [184]. Bovine mammary
alveolar epithelial (MAC-T) cells were used as an in vitro model of infection. MAEC
strains M45, M93, M111, and G1 were grown overnight, diluted in PBS, and used to
inoculate MAC-T cells at a multiplicity of infection (MOI) of 10 (approx. 6x106 bacterial
cells per well). The cultures were incubated at 37°C for 1 hour before weakly adherent

Figure 3-3: Adhered CFUs of each MAEC strain. M45 (brown), M93 (cyan), M111 (pink),
and G1 (blue) were incubated with MAC-T cells and the adhered CFUs were enumerated. The
wild type of each strain is shown on the left, the ΔchiA mutants in the middle, and ΔchiA
mutants containing pWH01 on the right. One-way ANOVA with Tukey’s correction was used
to determine statistical differences. Displayed statistics are the comparison to the wild type of
each respective strain. *p=0.05, **p>0.05, ***p=0.0001, ****p>0.0001.
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Figure 3-4: Adhered CFUs of M45 Following Incubation with MAC-T Cells for 1
hour. WT=wild type. ** p≤0.01 as determined by One-way ANOVA with Tukey’s

correction

bacteria were washed off using PBS, and the MAC-T cells were lysed with 0.1% Triton X100. The solution was then serially diluted and plated on LB agar to enumerate the
colony-forming units (CFUs) of adherent bacteria. Figures 3-4 through 3-7 show
obtained using individual MAEC strains while Figure 3-3 shows the data from all strains
compared with each other.
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Figure 3-5: Adhered CFUs of M93 Following Incubation with MAC-T Cells for 1
hour. WT= wild type. *** p=0.001, ****p>0.0001 as determined by One-way ANOVA with
Tukey’s correction

M45ΔchiA showed an approximately 2-fold reduction compared to the wild-type
(3.1x105 vs 7.2x105 CFUs, respectively) as shown in Figure 3-4. This phenotype was
restored upon reintroduction of chiA into the strain with pWH01. A one-way ANOVA
showed that the reduction in adhesion was statistically significant between the wild type
and the mutant (p=0.008) indicating that ChiA plays a role in adhesion to MAC-T cells.
A greater reduction was observed in M93 (>6-fold) between the wild type and
mutant (Figure 3-5), which was also complemented by the pWH01 plasmid. This
difference was also statistically significant when the two were compared (p=0.0001)
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Figure 3-6: Adhered CFUs of M111 Following Incubation with MAC-T Cells for 1 hour. WT=
wild type. *p<0.05 as determined by One-way ANOVA with Tukey’s correction

using a one-way ANOVA. M45 and M93 were both highly competitive in a murine model
of mastitis [99], and both appear to utilize ChiA in adherence to epithelial cells.
Unlike M45 and M93, M111 did not seem to rely on ChiA for adherence. There
was slight reduction in adherent CFUs, when M111ΔchiA was compared to the wild type
(9.7x105 vs 1.5x106, respectively), there was no statistically significant difference
(p=0.0606) (Figure 3-6). Other adhesive factors such as fimbriae play an important role
in adhesion in other strains of MAEC [102]. It is possible that while the small decrease
found in M111ΔchiA is not statistically significant, ChiA may be a secondary method of
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Figure 3-7: Adhered CFUs of G1 Following Incubation with MAC-T Cells for 1 hour. WT= wild
type. ****p<0.0001 as determined by One-way ANOVA with Tukey’s correction

adhesion and other factors such as pili or fimbriae play the more direct role. Future
investigation into this strain should focus on other adhesins that are found in M111 and
determine if they play a more significant role than ChiA.
Deletion of chiA in G1 caused the largest, most significant reduction in adhesion
of all MAEC strains investigated. G1ΔchiA presented almost a 10-fold decrease in
adhesion when compared to the wild type as shown in Figure 3-7. Wild type G1 resulted
in an average of 9.65x105 adhered CFUs while G1ΔchiA had an average of 9.95x104
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adhered CFUs. This difference was statistically significant (p<0.0001). Wild-type levels
of adhesion were restored upon complementation with plasmid pWH01.
G1 was isolated from a very severe, per-acute mastitis infection that resulted in
gangrene and severe tissue damage. Bacterial adhesion results in inflammation [198,
199]. An excessive amount of inflammation can result in permanent tissue damage
[200, 201] with this damage being deleterious to the health of the host. In mastitis, this
can result in the cow having significantly reduced milk production, repeated infections,
and even early culling of the cow [9, 152, 153]. The reduction of adhesion in G1ΔchiA
indicates ChiA is used to facilitate adhesion between strain and MAC-T cells, perhaps
through binding to host proteins such as CHI3L1.
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3.3 Identification of Putative Virulence Factors in Shows Insight Observed Phenotypes
of 4 MAEC Strains
Many genes coding for virulence factors described in other pathogenic strains of
E. coli are found in MAEC genomes, but very few are known to contribute to virulence
or pathogenicity of MAEC [99-101, 202]. Recently, the ferric dicitrate transport system
(fecABCDE) was proven to be vital for the growth of MAEC in raw milk [99]. This
operon is highly expressed and over-represented in MAEC genomes compared to other
strains [203, 204]. Swarming motility is the only phenotype that has been
experimentally associated with severity of infection with strains isolated from severe
mastitis exhibiting more swarming motility than those isolated from mild cases [205].
In order identify potential virulence factors, present in MAEC strains M45, M93,
M111, and G1, the assembled draft genomes of each strain was analyzed using Virulence
Factor Database 2.0 (Institute of Pathogen Biology, Beijing,
http://www.mgc.ac.cn/VFs/) [187]. The analysis revealed 40 unique virulence factors.
These were grouped based on their functions described in other strains of pathogenic E.
coli. Groups consisted of genes coding for adhesins (n=11), autotransporters (n=4),
antibiotic resistance (n=1), type 6 secretion system (n=2), complement resistance (n=3),
invasins (n=2), siderophores (n=5), and toxins (n=6). Other genes were identified with
unknown function (n=3) as well as SopA-like effectors of a type 3 secretion system
(n=3).
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Table 3-1: Genes Coding for Possible Virulence Factors found in MAEC strains M45, M93, M111,
and G1
Function*

Virulence factor

Strains present in

Reference

CFA/I fimbriae

M45

[206]

E. coli common pilus
(ecpABCDER)
Intimin-like adhesin
(eaeH)
Laminin binding
fimbriae (elfABCDG)
Adhesin

Hemorrhagic coli
pilus
P fimbriae
Type 1 pilus
(fimABCDEFGHI)

Autotransporter/Biofilm
formation

M45, M93, M111, G1
M45, M93, M111, G1
M45, M111
M45, M93, M111, G1
M45, M93, G1
M45, M93, M111, G1

[207]
[208]
[209]
[210, 211]
[212-214]
[215, 216]

K88 fimbriae

M111

[217, 218]

Long polar fimbriae

M45

[219]

Mam7

M45, M93, M111, G1

[220, 221]

Yad Fimbriae

M111, G1

[115, 222]

Antigen 43 (agn43)†

M111

[223]

ehaB†

M45, M93, M111, G1

[224]

Vacuoloating
autotransporter toxin

[225]
M93, G1

(vat)

Complement Resistance

Invasin
Siderophore

upaG†

M45, G1

[226]

OmpT

M45, M93, M111, G1

[205]

TraT

M45, M93, M111, G1

[227, 228]

iss

M45, M93, M111, G1

[229]

ibeA

M93, G1

ibeBC

M45, M93, M111, G1

Aerobactin
(iucABCD/iutA)

M45, G1

[230, 231]
[232]
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Heme uptake

(chuASTUWXY)
Iron/Manganese
transport (sitABCD)
Salmochelin
(iroBCDEN)

M93, G1
M45, M93, M111, G1
M45, M93

Yersiniabactin (fyuA,
irp1/2,

[233]
[234]
[235, 236]
[237-239]

M45, M93, G1

ybtAEPQSTUX)
Type 6 Secretion System

ace T6SS operon

M45, M93, M111, G1

[240]

Sci-1 T6SS

G1

[241]

Cytolethal distending
toxin (cdtB)
clbB
Alpha-Hemolysin
(hlyABCD)
Toxin

G1
G1
M111, G1

Hemolysin E
/Cytolysin A

[242]
[243, 244]
[245, 246]
[247, 248]

M111

(hlyE/cylA)‡
Cytotoxic necrotizing
factor (cnf1)
Colicin-like usp
Antibiotic Resistance
SopA-like T3SS effectors
Unknown Function††

Tetracycline efflux
pump (tetA)

G1
G1
G1

[249-251]
[252]
[253]

espX1, espX4, espX5

M45, M93

[254]

espL1

M45, M93, M111, G1

[254]

espL4

M45, M93

[254]

espR1

M111

[254]

*Functions are based on previously described functions shown in other pathogenic strains of E. coli
†Multifunctional as adhesin
‡Also called Silent Hemolysin A (SheA) or Avian Hemolysin
††Each of these genes have been described as pseudogenes from lambdoid phage that border a
pathogenicity island, but their precise function has not been shown

M111 showed the lowest level of adhesion of all 4 MAEC strains as discussed in
Section 3.2 of this thesis. It was the only strain that did not demonstrate a statistically
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significant reduction in adhesion to epithelial cells in the absence of chiA. A plausible
explanation for this is the presence of alternative adhesion factors. Even though it
showed the lowest level of adherence, M111 contained genes for 8/11 adhesins as wells as
two autotransporters that function in both biofilm formation and adhesion. The
diversity of adhesive structures encoded by M111 offers a plausible explanation for its
lack of reliance on ChiA.
Interestingly, M93 and G1 only contained genes for 5/11 adhesins found in the
analysis but showed the largest reduction in adhesion to epithelial cells in the absence of
ChiA. Strain M111 contained genes coding for the K88 and laminin-binding fimbriae,
both of which are absent in G1 and M93. These two adhesins facilitate attachment to
different cell types and be important for other pathotypes of E. coli [209, 217, 218].
The K88 fimbriae is commonly found in enterotoxigenic E. coli (ETEC),
specifically in strains that cause diarrhea in young pigs [218]. There are three different
serological variants of K88 found in nature: K88ab, K88ac, and K88ad [217, 255, 256].
This has largely been investigated in respect to its ability to promote adhesion to porcine
erythrocytes by binding to components of the extracellular matrix like fibronectin.
Fibronectin is expressed by MAC-T cells and is important for adherence and invasion of
S. aureus in vitro [257-259]. MAEC strains encode K88 pili at similar rates to other E.
coli pathotypes [260, 261] therefore, the extent of its role in MAEC virulence has not
been investigated.
The E. coli laminin-binding fimbriae (ELF) is highly prevalent in
enteropathogenic E. coli (EPEC) strains and is also common in MAEC [262]; Other
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mastitis pathogens such as S. aureus and Streptococcus uberis encode proteins of
similar function [263-266]. The ELF operon consists of 5 genes, elfABDCG, with the
major fimbrial subunit ElfA being the main attachment protein. It is related to G
fimbriae in uropathogenic E. coli which binds laminin present in the extracellular
matrix [209, 267]. Laminin is not produced by MAC-T cells in vitro but is present in the
mammary gland in vivo [268], offering a plausible explanation for M111’s apparent
decreased reliance on ChiA for adhesion. MAEC is known to be able to bind to laminin
present in the extracellular matrix, but ELF has not been experimentally shown to
contribute to MAEC virulence.
M111 contains genes coding for both Antigen 43 (Ag43) and EhaB. Both of these
proteins are classified as autotransporters which have been shown to influence cellular
aggregation and biofilm formation [223, 224]. Ag43 mediates bacteria-to-bacteria
interactions, auto-aggregation, and is important for survival and persistence of
uropathogenic E. coli (UPEC) in the urinary tract [269, 270]. EhaB binds components of
the extracellular matrix like laminin and collagen I in the digestive tract of cattle
challenged with E. coli O157:H7 [224], similar to ELF. Both Ag43 and EhaB are also key
factors in influencing biofilm formation in enterohemorrhagic E. coli [224, 269, 271].
The formation of biofilm is thought to contribute to persistent or chronic mastitis [98,
112, 244]. M111 may be able to utilize Ag43 and EhaB to facilitate adherence to epithelial
cells in a different manner than the other MAEC strains tested. However, the role of
these proteins in bovine mastitis remains uninvestigated.
In addition to these two fimbriae, the genome-wide association study (GWAS)
conducted by Olson et al. found that strains isolated from severe cases of mastitis were
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more likely to contain genes encoding the Yad fimbriae [99]. The Yad fimbriae are also
found in UPEC and APEC and contribute to colonization and environmental persistence
in some strains [272-274]. M111 and G1 contain genes coding for these fimbriae,
however, the role of this adhesin in the context of bovine mastitis has yet to be
investigated.
Interestingly, G1 contained the most genes for toxin production of all MAEC
strains analyzed (n=5). The high level of adhesion exhibited by G1 in combination with
the expression of these toxins might explain why it was isolated from a very severe,
gangrenous case of mastitis. M111 was the only other strain that contained genes coding
for toxins. Specifically, both M111 and G1 contain genes coding for an RTX toxin, alphahemolysin (HlyA). HlyA works by forming pores in the membrane of host cells and is
one of the most extensively studied exotoxins of pathogenic E. coli [275]. HlyA has been
proven to play an important role in the virulence of ExPEC in a mouse model [276] and
is known to cause lysis of epithelial cells as well [277]. It has been found in a large
variety of MAEC strains in many different areas of the world, indicating it might
contribute to the damage caused by these strains in the mammary gland [263, 276, 278,
279].
In addition, G1 contains genes the cytolethal distending toxin (CDT). CDT is a
heterotrimeric AB toxin that causes cell cycle arrest in mammalian cells. The active
subunit, CdtB, shares a high level of homology with mammalian DNase I and is able to
directly damage DNA to cause cell cycle arrest and as a result, induce apoptosis [280].
CDT has been described previously in many different MAEC strains as well, though its
role or effect in virulence or severity is not yet known [119, 276, 281]. These two toxins
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in addition to the other toxins genes found could help explain the high severity of
mastitis G1 is able to cause.
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SECTION 4: CONCLUSIONS AND FUTURE DIRECTIONS
My results demonstrate that ChiA can play an important role in the adhesion of
MAEC to bovine mammary epithelial cells. A GWAS study showed that ChiA and the
type-two secretion system found adjacent to it were positively associated with
colonization of mouse mammary glands during a mastitis model of infection [99, 115].
Future work should include determining whether ChiA function in MAEC strains is
dependent on the adjacent type two secretion system.
In these studies, I aimed to investigate environments relevant to bovine mastitis
that might be able to induce expression of chiA. Flow cytometry showed promoter
activity of chiA was significantly increased in hypoxic environments and in the presence
of bile salts but not both. It is possible that specific bile salts influence the expression of
chiA in a similar manner to V. parahaemolyticus [195, 282]. There are many other
conditions relevant to mastitis that have yet to be investigated. These include growth in
milk and in the presence of polymorphonuclear neutrophils. In addition, I did not
confirm these results with qPCR in this thesis. This could also be investigated using
RNA-sequencing or other types of reporter assays. The regulation of chiA is an area for
further investigation. Previous research indicates it is constitutively silenced by H-NS
binding to its promoter, but this has only been confirmed in the lab strain, K-12.
Isogenic mutants of hns or conditions that repress H-NS binding such as overexpression of Lon protease or PhoP mediated displacement from DNA can be used to
demonstrate this mechanism in multiple strains of MAEC.
While chiA is annotated as a chitinase [165] its role in bovine mastitis may not be
dependent on its enzymatic activity. The chitin binding domains of ChiA, found through

57
homology to other chitinases, might be responsible for its role in adhesion. When chiA
was deleted in 4 different MAEC strains of various genetic backgrounds and phenotypes,
adhesion to MAC-T cells in vitro was significantly decreased in 3 out of 4 strains. The
interaction between ChiA and host cells might be facilitated through its interaction with
the chitinase-like protein, CHI3L1.
Chitinase-like proteins (CLPs) are expressed in response to pathogens that are
chitinous and those that are chitin-lacking [283-286]. CLPs are also expressed during
non-infectious diseases such as cancer or kidney injuries [287-289]. CHI3L1 is a CLP
that is upregulated in response to mammary infection with coliform bacteria such as
MAEC. Its expression in the mammary gland is controlled by caspase activity,
independent of bacterial load or cytokine levels [159].
When CHI3L1 is expressed, it promotes the movement of leukocytes from the
interstitial space to the alveolar lumen in mammary tissue [159, 290]. It also promotes
increased proliferation of mammary epithelial cells and reduces apoptosis [291]. In the
absence of CHI3L1, migration, maturation, and activation of macrophages is
significantly impaired [290, 292]. Since ChiA binds to CHI3L1 [177], it is probable that
MAEC expressing and secreting ChiA into the mammary gland are able to suppress
these innate immune responses. This would allow them to persist longer in mammary
glands, explaining the results from Olson et al. showing that strains that are more
prevalent at later time points in an infection are more likely to possess chiA [99], though
this possible interaction has not been investigated in a mammary gland setting.

58

Figure 4-1: Possible Mechanism of Attachment via ChiA. In order for this interaction to
occur as described in this thesis, IL13Rα2 must be N-glycosylated. In the absence of
glycosylation, ChiA may still be able to bind CHI3L1, but this interaction will not
facilitate adhesion since CHI3L1 will only bind to glycosylated IL13Rα2.

ChiA-mediated adhesion might occur when CHI3L1 is bound to interleukin-13
receptor α-2 (IL13Rα2) and IL-13 in a multimeric complex [292]. Recently, the
formation of this complex was found to be heavily dependent on N-glycosylation [293].
Low et al. also showed that N-glycosylation is important for binding to be mediated
between ChiA and CHI3L1 in an in vitro model of intestinal epithelial cells [177]. Since
CHI3L1 is found in the extracellular matrix and is soluble in milk [159, 181, 293], the
complex it forms with IL13Rα2 and IL-13 is likely the only time it is found tethered to
the cell membrane. MAEC strains that possess chiA would be able to take advantage of
this and bind to CHI3L1 while it is in this protein complex, bringing the bacterium in
proximity to the cell, allowing colonization of the epithelium, invasion into tissue, and
persistence in the mammary gland. Further investigation to confirm this possible
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interaction should focus on the role that host proteins, CHI3L1, IL-13, and IL13Rα2,
play. Cell lines that exhibit repressed or reduced expression of the genes for these
proteins would work to confirm this interaction.
Alternatively, it is possible that ChiA does not directly bind to host proteins.
Chitinases in S. typhimurium and S. typhi have been shown to modify host
glycoproteins by digesting glycosyl groups present in the extracellular matrix. This
results in mannose residues present on the cell surface becoming more available for
attachment through type I fimbriae [174, 175]. Since ChiA shares homology with these
chitinases (see Supplementary Figure 5), it is plausible it performs a similar function.
ChiA might also have other functions outside of adhesion.
Chitinases in other bacterial species are known to increase survival in phagocytes
by dampening the expression of host antimicrobial responses in dendritic cells and
macrophages [175]. MAEC could use ChiA in a similar manner allowing for greater
persistence in the mammary gland. This is a possible explanation for the results of
Olson et al. showing that MAEC strains that were more prevalent in later stages of
mouse and bovine models of mastitis were more likely to contain chiA [99, 115].
The translocation of ChiA from the periplasm to outside of the cell is facilitated
by a type-two secretion system that is found adjacent to chiA [165]. While the ability of
chitinases found in other gram-negative bacteria to become anchored to the outer
membrane has been demonstrated [176], this has not yet been demonstrated in E. coli.
This topic should be investigated through localization studies utilizing immunoblotting
and cell fractionization or confocal microscopy. For instance, the localization of ChiA in
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the outer membrane could be detected by cell fractionization studies using an epitope
tag such as a hemagglutinin A tag or antibodies specific to ChiA.
I also demonstrated that MAEC strain M111 possesses multiple alternative
adhesive factors that offer a plausible explanation for its lack of a significant decrease in
adhesion to MAC-T cells in the absence of ChiA. These include the K88 and ELF
proteins that bind to glycoproteins and laminin, respectively [209, 218]. Numerous
glycoproteins and possible lectins for the K88 fimbriae are present on MAC-T cells
[112], however, laminin is not produced by these cells in vitro [268]. Creating isogenic
mutants that cannot synthesize these adhesins and measuring any loss of adhesion in
vitro is the initial step that should be taken. If a significant role for these adhesins is
found in vitro, a mouse model of mastitis with the isogenic mutants for these adhesins
would confirm any loss of virulence or ability to colonize mammary glands that may
result.
I analyzed the genomes of each of the 4 MAEC strains for additional virulence
factors. The annotated draft genomes of each strain were analyzed using the Virulence
Factor Database. This resulted in 40 unique virulence factors being identified. G1
contained a higher number of genes for toxins than other MAEC strains analyzed. These
toxins include α-hemolysin and cytolethal distending toxin among several others. The
different toxins contained within G1 offer insight into the virulence and presentation of
severe, gangrenous mastitis observed when it was isolated.
Better understanding MAEC virulence factors may help distinguish these bacteria
from other ExPEC strains and will lead to the identification of novel targets for
antimicrobials in both veterinary and human treatments. Despite the high prevalence of
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genes for multiple virulence factors in many strains of MAEC, very few have been shown
to play a significant role in the ability of these bacteria to cause mastitis. The impact of
ChiA on adherence that I demonstrated as well as other adhesive factors I have
described provide opportunities for further investigation.
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Inoculum

Appendix A: Supplementary figures

Supplementary Figure 1: Percent of Adhered CFUs Relative to Original Inoculum of M45 to
MAC-T cells. Percentage of adhered CFUs relative to the original number of CFUs added into
MAC-T cells. **p>0.01, ***p=0.001 as determined by One-Way ANOVA with Tukey’s
correction
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Supplementary Figure 2: Percent of Adhered CFUs Relative to Original Inoculum of M93 to
MAC-T cells. Percentage of adhered CFUs relative to the original number of CFUs added into
MAC-T cells. ***p=0.001 as determined by One-Way ANOVA with Tukey’s correction
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Supplementary Figure 3: Percent of Adhered CFUs Relative to Original Inoculum of M111 to
MAC-T cells. Percentage of adhered CFUs relative to the original number of CFUs added into
MAC-T cells. *p<0.05 as determined by One-Way ANOVA with Tukey’s correction
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Supplementary Figure 4: Percent of Adhered CFUs Relative to Original Inoculum of M111 to
MAC-T cells. Percentage of adhered CFUs relative to the original number of CFUs added into
MAC-T cells. ****p<0.001 as determined by One-Way ANOVA with Tukey’s correction
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Supplementary Figure 5: Multisequence Alignment of 5 Unique Chitinase Protein Sequences
from S. typhimurium, S. typhi, L. pneumophilia, and MAEC strain G1.
Genes encoding for Glycosyl Hydrolase Family 18 proteins were aligned using COBALT.
Sequences are from top to bottom: MAEC strain G1, L. pneumophilia strain 130b, L.
pneumophilia strain C9_S, S. enterica serovar Typhimurium strain 14028S, and S. enterica
serovar Typhi strain CT18.

